Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease

M A Monroy1, F P Ross, S L Teitelbaum

  • 1Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Bone
|February 22, 2002
PubMed

Insights

Mucopolysaccharidosis type VII (MPS VII), a lysosomal storage disease, causes skeletal deformities due to impaired beta-glucuronidase activity. This study reveals abnormal osteoclast function and reduced bone formation in MPS VII mice, contributing to skeletal defects.

Area of Science:

  • Biochemistry
  • Genetics
  • Skeletal Biology

Background:

  • Mucopolysaccharidosis type VII (MPS VII) is a genetic lysosomal storage disorder resulting from beta-glucuronidase (GUSB) deficiency.
  • This deficiency leads to the accumulation of glycosaminoglycans, causing widespread tissue damage and skeletal deformities.
  • A murine model of MPS VII exhibits similar skeletal dysplasia to human patients.

Purpose of the Study:

  • To investigate the cellular and functional abnormalities of osteoclasts in MPS VII mice.
  • To determine the impact of GUSB deficiency on bone formation rates.
  • To elucidate the mechanisms underlying skeletal defects in MPS VII.

Main Methods:

  • Ultrastructural analysis of osteoclast morphology and bone surface interaction.
  • In vitro bone resorption assays using MPS VII and wild-type osteoclasts.
  • Bone marrow transplantation experiments to assess donor osteoclast function in MPS VII recipients.
  • In vivo calcein labeling to measure bone formation rates.

Main Results:

  • MPS VII osteoclasts exhibited abnormal morphology, including a lack of ruffled borders and detachment from bone.
  • Bone marrow transplantation normalized osteoclast morphology and function in MPS VII recipients.
  • MPS VII osteoclasts showed significantly reduced in vitro bone resorption capacity.
  • MPS VII mice displayed a slower rate of bone matrix deposition in the epiphysis.

Conclusions:

  • Abnormal osteoclast morphology and function, coupled with impaired bone matrix deposition, contribute to the skeletal dysplasia observed in MPS VII.
  • GUSB deficiency directly impacts osteoclast activity and bone formation, highlighting a critical role in skeletal integrity.
  • The MPS VII mouse model provides valuable insights into the pathogenesis of skeletal defects in this lysosomal storage disease.